Abdul, Mussah H.
HRN: 21-21-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2022
CEFTAZIDIME 1GM (VIAL)
04/07/2022
04/14/2022
IV
1gm
Q8
Bronchiectasis, CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes